Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.3.3 was added to the history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T23:06:39.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    The page history shows an added revision (v3.3.2) and a removed revision (v3.2.0); this reflects a UI/system update with no substantive changes to the study record.
    Difference
    0.1%
    Check dated 2025-11-25T11:57:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Removed a government funding/operating status notice from the page, a minor administrative update that does not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:17:22.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The new screenshot adds an extra version entry to the record history and shows minor UI tweaks; the primary study information and history structure remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T21:24:21.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Summary of changes: added a government-operating-status notice and new v3.2.0 version tag; removed the old v3.1.0 tag. The page now communicates current funding-related limitations and where to check status, marking a conduction of a software/website update.
    Difference
    11%
    Check dated 2025-10-06T06:58:40.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    - Page revision updated from v3.0.2 to v3.1.0. - No changes to core content, pricing, stock, or names; overall content meaning remains the same.
    Difference
    0.3%
    Check dated 2025-09-29T03:40:41.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.